
Background Knee osteoarthritis and other causes of knee pain can limit participation in inpatient rehabilitation, particularly among older, medically complex patients. Cryoneurolysis may provide sustained, drug-free analgesia by temporarily interrupting sensory nerve conduction while preserving nerve structure. Objective To evaluate the effects of ultrasound-guided cryoneurolysis on knee pain, range of motion, and functional independence in the in-patient setting. Methods This single-centre prospective cohort study included 15 patients with knee pain, diagnosed with arthritis on recent x-rays that interfered with mobility, transfers, or rehabilitation participation. Following a positive diagnostic nerve block, cryoneurolysis targeted the infrapatellar branch of the saphenous nerve and/or anterior femoral cutaneous nerve branches. Outcomes were assessed at baseline and at 1 week, 1 month, and 3 months. Measures included the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), knee flexion active and passive range of motion, and the motor Functional Independence Measure (FIM). Linear mixed-effects models evaluated changes over time. Results Participants had a median age of 82 years. WOMAC pain, function, and total scores improved significantly at all follow-up points. Passive knee flexion increased by 15.90° at 1 week, 17.69° at 1 month, and 17.40° at 3 months. Active knee flexion increased significantly by 11.30° at final follow-up. Motor FIM scores improved by 11.00 points in 3 months. No immediate or delayed procedure-related adverse events were observed. Conclusion Cryoneurolysis was associated with sustained improvements in pain, knee motion, and functional independence in older rehabilitation inpatients. Larger controlled studies are required to confirm efficacy, durability, and generalizability and determine effects on rehabilitation participation.
Background Arthrogenic muscle inhibition (AMI) following knee injury is difficult to measure feasibly, necessitating alternative approaches. Given its multifactorial nature, an improved understanding of how AMI manifests clinically and aligns with established mechanisms of muscle dysfunction is required. Purpose This review aimed to a) identify AMI manifestations, b) map AMI manifestations to mechanistic pathways, c) characterize knowledge gaps regarding AMI identification. Design Scoping review. Methods A comprehensive multi-database search (PubMed, Embase, and Scopus) was conducted for primary studies published between January 1, 2000, and December 10, 2025. Two reviewers independently performed study screening and selection, with data extraction completed by three blinded reviewers. English-language studies reporting assessment and/or treatment outcomes following knee structural injury were included. Identified AMI manifestations were subsequently mapped to previously described central, reflexive, and peripheral mechanisms. Results From 1,283 identified records, 289 studies met the inclusion criteria. Most studies examined anterior cruciate ligament reconstruction (79.2%) and included mixed-sex cohorts (56.1%). The most frequently reported AMI manifestations were deficits in knee strength, activation, and biomechanics, predominantly mapped to reduced descending motor output (84.4%). In contrast, Hoffmann reflex testing, one of the most direct assessments of AMI, was infrequently employed (5.5%). Other direct assessments, including central/neurophysiological measures, were infrequently utilized (14.9%). Conclusion This review provides the first comprehensive, mechanism-based synthesis of AMI manifestations following knee structural injury. Current literature is heavily focused on knee strength and activation deficits, with sensory, reflexive, and cortical mechanisms substantially underrepresented. These findings support developing a mechanism-informed framework for AMI management. Clinical Relevance Over-reliance on strength-based assessments may underestimate important sensory, reflexive, and central contributors to AMI following knee injury. While the direct measurement of AMI is not feasible in clinical settings, the mechanism-anchored manifestations identified in the current review may aid clinicians in early identification and management of AMI following knee injuries.